Related Experiment Video
Updated: Jun 17, 2026
Disruption of the Mouse Blood-Brain Barrier by Small Extracellular Vesicles from Hypoxic Human Placentas
Published on: January 26, 2024
sP-selectin in preeclamptic pregnancies with intrauterine normal growth and small-for-gestational-age foetus.
Marzena Laskowska1, Katarzyna Laskowska, Bozena Leszczyńska-Gorzelak
1Department of Obstetrics and Perinatology Medical University of Lublin, ul. Jaczewskiego 8, 20-950 Lublin. melaskowska@go2.pl
Insights
Maternal serum soluble P-selectin (sP-selectin) levels were elevated in severe preeclampsia. The highest sP-selectin levels were observed in preeclamptic patients with appropriate-for-gestational-age infants, suggesting a potential role in preeclampsia.
Area of Science:
- Obstetrics and Gynecology
- Maternal-Fetal Medicine
- Immunology
Background:
- Preeclampsia is a severe pregnancy complication characterized by hypertension and organ damage.
- Intrauterine growth restriction (IUGR) is a common complication of preeclampsia.
- Soluble P-selectin (sP-selectin) is a marker of endothelial activation and inflammation.
Purpose of the Study:
- To compare maternal serum sP-selectin levels in severe preeclampsia with normal fetal growth versus small-for-gestational-age (SGA) fetuses.
- To investigate the association between sP-selectin and preeclampsia severity.
Main Methods:
- Maternal serum sP-selectin concentrations were measured using ELISA.
- Study groups included patients with preeclampsia and IUGR (group PI), preeclampsia with appropriate-for-gestational-age infants (group P), and healthy controls (group C).
Main Results:
- Maternal serum sP-selectin levels were significantly higher in women with severe preeclampsia compared to normotensive controls.
- The highest statistically significant sP-selectin levels were found in preeclamptic patients with appropriate-for-gestational-age infants.
Conclusions:
- Increased maternal serum sP-selectin levels are associated with severe preeclampsia.
- Further research is needed to confirm this association and elucidate the clinical significance and causative role of sP-selectin in preeclampsia pathogenesis.
Aim:
The aim of this study was the comparative analysis of the sP-selectin in pregnancies complicated by severe preeclampsia with intrauterine normal growth and small-for-gestational-age foetus.
Patients And Methods:
The study was carried out on 14 patients with preeclampsia complicated by intrauterine growth retardation (group PI) and 13 preeclamptic patients with appropriate-for-gestational-age weight infants (group P). The control group consisted of 13 healthy normotensive pregnant patients with singleton uncomplicated pregnancies (group C). Maternal serum soluble P-selectin concentrations were estimated using sandwich ELISA assay according to the manufacturer's instructions.
Results:
Pregnant women with severe preeclampsia had higher maternal serum sP-selectin levels than the normotensive controls. The sP-selectin levels were highest and statistically significant in preeclamptic patients with appropriate-for-gestational-age weight infants.
Conclusions:
Our findings indicate an association between the increased levels of sP-selectin and severe preeclampsia. However, further studies are required to validate this association and explore the possibility of clinical importance and causative role of sP-selectin in the pathogenesis of preeclampsia.
